226 related articles for article (PubMed ID: 36068379)
1. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
[TBL] [Abstract][Full Text] [Related]
2. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
6. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
7. Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort Study.
Chen Y; Zhu D; Chen M; Xu Y; Ye Q; Wang X; Xu P; Feng Q; Ji M; Wei Y; Fan J; Xu J
Clin Colorectal Cancer; 2023 Dec; 22(4):464-473.e5. PubMed ID: 37730473
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: a retrospective cohort study.
Kim NR; Alhothaifi ED; Han DH; Choi JS; Choi GH
World J Surg Oncol; 2023 Jun; 21(1):169. PubMed ID: 37280633
[TBL] [Abstract][Full Text] [Related]
9. Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy.
Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
Int J Colorectal Dis; 2021 Apr; 36(4):767-778. PubMed ID: 33420522
[TBL] [Abstract][Full Text] [Related]
10. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
11. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Okuno M; Hatano E; Toda R; Nishino H; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokuka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):496-509. PubMed ID: 32362018
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
[TBL] [Abstract][Full Text] [Related]
13. Impact of autotransfusion on recurrence of colorectal cancer liver metastasis: Long-term follow-up of patients undergoing curative intent hepatectomy.
Wehrle CJ; Perlmutter B; Hong H; Chang J; Stackhouse KA; Naples R; Shanaz Hossain M; Joyce D; Simon R; Kim J; Naffouje SA; Aucejo F; Kwon DCH; Walsh RM; Augustin T
J Surg Oncol; 2024 Mar; 129(4):793-801. PubMed ID: 38151831
[TBL] [Abstract][Full Text] [Related]
14. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.
Neofytou K; Giakoustidis A; Neves MC; Morrison D; Giakoustidis D; Khan AZ; Stebbing J; Mudan S
Langenbecks Arch Surg; 2017 Jun; 402(4):599-605. PubMed ID: 27043945
[TBL] [Abstract][Full Text] [Related]
15. The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator.
Xu Y; He J; Li W; Zhang W; Liu S; He J; Pan Z; Lu Z; Peng J; Lin J
Pathol Oncol Res; 2022; 28():1610663. PubMed ID: 36147656
[No Abstract] [Full Text] [Related]
16. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
[TBL] [Abstract][Full Text] [Related]
17. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
18. Colon inflammatory index as a useful prognostic marker after R0 resection in patients with colorectal cancer liver metastasis.
Ishii M; Tominaga T; Nonaka T; Oyama S; Moriyama M; Maruyama K; Sawai T; Nagayasu T
PLoS One; 2022; 17(10):e0273167. PubMed ID: 36194563
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study.
Han L; Xue J; Wu X; Liang G; Wu Y; Guo F; Gao S; Sun G
Ann Palliat Med; 2022 Feb; 11(2):717-729. PubMed ID: 35249349
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.
Hallet J; Tsang M; Cheng ES; Habashi R; Kulyk I; Hanna SS; Coburn NG; Lin Y; Law CH; Karanicolas PJ
Ann Surg Oncol; 2015 Nov; 22(12):4038-45. PubMed ID: 25752895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]